Ziarco

Developer of treatments for chronic inflammatory skin disorders like eczema

placeSandwich, England, United Kingdom calendar_todayFounded 2012 groups3 employees language ziarcopharma.com

Registered entities

Innovation

4 patent families (2 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 17 times.

YearFilings
20141
20161
20181
20191
20201
20212

Investor mix

6 investors on record; lead investors include BVF Partners, New Enterprise Associates, Lundbeck Foundation; 3 have since exited.

Investor typeCountShare
Venture capital350%
Private equity233%
Other / undisclosed117%
Coming soon